Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 50: 1674-1675, 2004; 10.1373/clinchem.2004.036392
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marshall, T.
Right arrow Articles by Williams, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marshall, T.
Right arrow Articles by Williams, K. M.
Related Collections
Right arrow General Clinical Chemistry
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 2004;50:1674-1675.)
© 2004 American Association for Clinical Chemistry, Inc.


Technical Briefs

Elimination of the Interference from Aminoglycoside Antibiotics in the Pyrogallol Red-Molybdate Protein Dye-Binding Assay

Thomas Marshalla and Katherine M. Williams

1 Analytical Biochemistry Group, Sunderland Pharmacy School, The University of Sunderland, Sunderland SR1 3RG, UK;

aauthor for correspondence: fax 44-191-515-3405, e-mail tom.marshall{at}sunderland.ac.uk

The Pyrogallol Red-molybdate (PRM) protein dye-binding assay is used for urinary protein determination (1)(2)(3). The assay is sensitive to interference from aminoglycoside antibiotics, and the extent of interference varies with different PRM reagents (1)(2)(4)(5)(6)(7). Thus, the Dade Behring PRM and the Sigma PRM assays are sensitive to aminoglycoside interference, whereas the Cobas Fara and Roche Integra 700 PRM assays are not (4)(5). Furthermore, the PRM reagents used by Fujita et al. (1) and Orsonneau et al. (3) are more sensitive to interference than the reagent used by Watanabe et al. (2). We have previously shown that the addition of sodium dodecyl sulfate (SDS) to the PRM reagent increases the interference, whereas the addition of sodium oxalate reduces the interference (6)(7). In the present study, we indicate that the extent of interference also depends on the concentration of dye in the reagent and demonstrate that a decrease in the dye concentration combined with an increase in the sodium oxalate concentration eliminates the interference.

The aminoglycosides (Sigma-Aldrich) were dissolved in water at a concentration of 10 g/L. The neomycin and gentamicin were further diluted to 1 g/L. Pierce Prediluted Protein Assay Standard (1 g/L bovine serum albumin) was purchased from Perbio Science UK Ltd. Urine control (cat. no. AU2353) was purchased from Randox Laboratories Ltd. and reconstituted in deionized water or aqueous aminoglycoside (final concentration, 0.2 or 1.0 g/L).

The Watanabe dye reagent was freshly prepared by dissolving 5.9 g of succinic acid and 0.5 g of sodium benzoate in 900 mL of water and mixing with 40 mL of dye solution [60 mg of Pyrogallol Red (cat. no. P8759; Sigma-Aldrich Co. Ltd.) in 100 mL methanol]. We then added 4 mL of 2.4 g/L disodium molybdate and 4 mL of 35 g/L sodium oxalate, adjusted the mixture to pH 2.5 with 0.5 mol/L hydrochloric acid, and brought the final volume to 1 L with deionized water (2). We modified the Watanabe reagent (0.06 mmol/L dye and 1.0 mmol/L sodium oxalate without SDS) by varying the concentration of the dye (0.03 or 0.12 mmol/L), sodium oxalate (0 or 2 mmol/L), and SDS (25 or 100 mg/L) in all combinations. For protein assays, we mixed 20 µL of sample, calibrator, or water (blank) with 1 mL of PRM reagent and measured the absorbance at 600 nm after 30 min against the blank.

The effects of the aminoglycosides on the absorbance readings in the PRM assay (in the absence of protein) with reagents at three different dye concentrations are shown in Table 1 . Doubling the concentration of the dye from 0.06 to 0.12 mmol/L increased the absorbance attributable to aminoglycoside by up to 273% (geneticin), whereas halving the concentration (0.03 mmol/L) decreased the absorbance by up to 87% (tobramycin). Doubling the concentration of the dye in combination with addition of SDS and omission of sodium oxalate increased the aminoglycoside interference by up to 2500% (amikacin). Halving the concentration of the dye and doubling the sodium oxalate concentration (with omission of SDS) eliminated the interference (Table 1 ). We confirmed the results, using urine control supplemented with aminoglycosides at the maximum concentrations expected in patients’ urines: 0.2 g/L amicakin, gentamicin, neomycin, or tobramycin; 1.0 g/L kanamycin or streptomycin (4)(8)(9). The measured protein concentration in the urine control was falsely increased by neomycin (67% higher), gentamicin (33%), tobramycin (26%), amikacin (9%), streptomycin (7%), and kanamycin (6%) when we used the Watanabe reagent but was unaffected by the aminoglycosides (respective values <1%) when we used the modified reagent (n = 4; CV <6%).


View this table:
[in this window]
[in a new window]
 
Table 1. Effect of varying the composition of the PRM reagent on the absorbance produced by the aminoglycosides in the absence of protein.1

In conclusion, the extent of aminoglycoside interference in the PRM assay is dictated by the composition of the dye reagent. SDS increases the interference (6), whereas sodium oxalate decreases the interference (7), and these effects are compounded by changes in the concentration of the dye. Thus, increased dye combined with the omission of sodium oxalate (plus SDS) gives very high interference, whereas decreased dye combined with increased sodium oxalate (minus SDS) eliminates detectable interference.


References

  1. Fujita Y, Mori I, Kitano S. Color reaction between Pyrogallol Red-molybdenum (VI) complex and protein. Bunseki Kagaku 1983;32:E379-E386.[ISI]
  2. Watanabe N, Kamel S, Ohkubo A, Yamanaka M, Ohsawa S, Makino K, et al. Urinary protein as measured with a Pyrogallol-Red-Molybdate complex manually and in a Hitachi 726 automated analyzer. Clin Chem 1986;32:1551-1554.[Abstract/Free Full Text]
  3. Orsonneau JL, Douet P, Massoubre C, Lustenberger P, Bernard S. An improved Pyrogallol Red-molybdate method for determining total urinary protein. Clin Chem 1989;35:2233-2235.[Abstract/Free Full Text]
  4. Koerbin G, Taylor L, Dutton J, Marshall K, Low P, Potter JM. Aminoglycoside interference with the Dade Behring Pyrogallol red-molybdate method for the measurement of total urine protein [Letter]. Clin Chem 2001;47:2183-2184.[Free Full Text]
  5. Marshall T, Williams KM. Total protein determination in urine: aminoglycoside interference [Letter]. Clin Chem 2003;49:202-203.[Free Full Text]
  6. Marshall T, Williams KM. Aminoglycoside interference in the Pyrogallol red-molybdate protein assay is increased by the addition of sodium dodecyl sulfate to the dye reagent [Letter]. Clin Chem 2003;49:2111-2112.[Free Full Text]
  7. Marshall T, Williams KM. Extent of aminoglycoside interference in the pyrogallol red-molybdate assay depends on the concentration of sodium oxalate in the dye reagent. Clin Chem 2004;50:934-935.[Free Full Text]
  8. Dollery C eds. Therapeutic drugs 1991;Vol. 1:A1-I131 Churchill Livingstone London. .
  9. Parfitt K eds. Martindale: the complete drug reference, 32nd ed 1999:112-270 Pharmaceutical Press Taunton. .




This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marshall, T.
Right arrow Articles by Williams, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marshall, T.
Right arrow Articles by Williams, K. M.
Related Collections
Right arrow General Clinical Chemistry
Right arrow Proteomics and Protein Markers


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS